Stock Price
5.99
Daily Change
0.04 0.67%
Monthly
7.93%
Yearly
11.96%
Q2 Forecast
5.82

Ardelyx reported $0 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2026 -0.12 -0.17 Apr/30




Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Amgen USD 5.29 0.35 Dec/2025
Ardelyx USD 0 0 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Curis USD 1.23 3.26 Dec/2025
Sanofi EUR 2.17 2.84 Mar/2026
TG Therapeutics USD 0.14 2.29 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Xoma USD -1.59 2.43 Sep/2024